Pneumoccal polysacchride conjugate vaccine
US9884113B2 · kind B2 · utility
10Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2015 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Jun 3, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various conjugated capsular saccharides from different S. pneumoniae serotypes conjugated to 2 or more different carrier proteins, where the composition comprises serotype 19F capsular saccharide conjugated to diphtheria toxoid (DT) or CRM197, optionally wherein 19F is the only saccharide in the composition conjugated to diphtheria toxoid (DT) or CRM197.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.